(Q43477895)

23 November 2017

title

HLA-DR antigen-negative acute myeloid leukemia (English)

1 reference

23 November 2017

1 reference

Wetzler M

1

1 reference

23 November 2017

McElwain BK

2

1 reference

23 November 2017

Stewart CC

3

1 reference

23 November 2017

Blumenson L

4

1 reference

23 November 2017

Mortazavi A

5

1 reference

23 November 2017

Ford LA

6

1 reference

23 November 2017

Slack JL

7

1 reference

23 November 2017

Barcos M

8

1 reference

23 November 2017

Ferrone S

9

1 reference

23 November 2017

Baer MR

10

1 reference

23 November 2017

publication date

1 April 2003

1 reference

23 November 2017

1 reference

23 November 2017

volume

17

1 reference

23 November 2017

issue

4

1 reference

23 November 2017

page(s)

707-715

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402865

23 November 2017

exact match

0 references

cites work

Analysis of HLA-DR expression on keratinocytes in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Is poor prognosis really related to HLA-DR expression by malignant melanoma cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Molecular oncogene markers and their significance in cutaneous malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Immunophenotypic and enzymatic studies do not support the concept of mixed monocytic-granulocytic differentiation in acute promyelocytic leukaemia (M3): a study of 44 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

The unique aspects of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARalpha mRNA using real-time reverse-transcription polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Use of a photolabeling technique to identify nonviable cells in fixed homologous or heterologous cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Immunophenotype of blast cells in acute myeloid leukemia may be a useful predictive factor for outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Transcriptional regulation of MHC class II genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Cross-presentation in viral immunity and self-tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

In situ expression of transforming growth factor ?? is associated with melanoma progression and correlates with Ki67, HLA-DR and ?? 3 integrin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

7 January 2021

Correlation of immunological surface antigens with survival in diffuse large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

7 January 2021

Expression of MHC class I and class II antigens in colonic carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

7 January 2021

Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

7 January 2021

Immunological definition of acute promyelocytic leukemia (FAB M3): a study of 39 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

7 January 2021

Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

7 January 2021

Acute myeloid leukemias M2 potentially misdiagnosed as M3 variant French-American-Britain (FAB) subtype: a transitional form?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

7 January 2021

Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

7 January 2021

Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

7 January 2021

Microgranular variant of acute promyelocytic leukemia in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

7 January 2021

HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402865

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402865

1 reference

Dimensions Publication ID

23 November 2017

1020144043

0 references

1 reference